Literature DB >> 6344619

Comparison of propranolol or hydrochlorothiazide alone for treatment of hypertension. III. Evaluation of the renin-angiotensin system.

E D Freis, B J Materson, V Flamenbaum.   

Abstract

In this study, the relation between renin activity and therapeutic response to hydrochlorothiazide or propranolol was studied. Patients with a diastolic blood pressure of 95 to 114 mm Hg were treated with propranolol (40 to 320 mg twice daily) or hydrochlorothiazide (25 to 100 mg twice daily). The initial renin profiles were: low, 56 percent (n = 300); normal, 33 percent (n = 174); high, 11 percent (n = 60). A greater incidence of low and fewer high renin profiles (p less than 0.001) were observed in blacks. After furosemide administration (40 mg intravenously), 55 percent of patients (n = 291) had a low renin response and 45 percent (n = 240) had a normal renin response. No correlation between renin profile and renin response was observed, although low renin response and low renin profile occurred more frequently in older patients. Hydrochlorothiazide administration resulted in a greater decrement in diastolic blood pressure (p less than 0.05) in the total group. Irrespective of renin activity, both hydrochlorothiazide and propranolol reduced diastolic blood pressure. When renin profile was considered, no significant variation in response to hydrochlorothiazide therapy was observed, and there was a greater reduction in diastolic blood pressure in the patients with a high renin profile receiving propranolol. In comparing therapeutic response, patients with a low renin profile had a better response to hydrochlorothiazide, and propranolol was more effective in patients with a high renin profile. The anticipated effect of therapy on plasma renin activity was observed. Although these results are consistent with a volume-vasoconstrictor analysis of hypertension, the results of therapy could not have been prejudged from renin profile or responsivity. The slight differences observed do not warrant the expense of renin determinations when a simple determination of therapeutic response is sufficient.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6344619     DOI: 10.1016/0002-9343(83)90812-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  16 in total

1.  Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertension.

Authors:  Stephen T Turner; Gary L Schwartz; Arlene B Chapman; Amber L Beitelshees; John G Gums; Rhonda M Cooper-DeHoff; Eric Boerwinkle; Julie A Johnson; Kent R Bailey
Journal:  Am J Hypertens       Date:  2010-08-19       Impact factor: 2.689

Review 2.  Management of hypertension in ethnic minorities.

Authors:  Jawad M Khan; D Gareth Beevers
Journal:  Heart       Date:  2005-08       Impact factor: 5.994

Review 3.  Clinical trials and transethnic pharmacology.

Authors:  M E Kitler
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

4.  Pharmacogenomic Genome-Wide Meta-Analysis of Blood Pressure Response to β-Blockers in Hypertensive African Americans.

Authors:  Yan Gong; Zhiying Wang; Amber L Beitelshees; Caitrin W McDonough; Taimour Y Langaee; Karen Hall; Siegfried O F Schmidt; Robert W Curry; John G Gums; Kent R Bailey; Eric Boerwinkle; Arlene B Chapman; Stephen T Turner; Rhonda M Cooper-DeHoff; Julie A Johnson
Journal:  Hypertension       Date:  2016-01-04       Impact factor: 10.190

5.  PTPRD gene associated with blood pressure response to atenolol and resistant hypertension.

Authors:  Yan Gong; Caitrin W McDonough; Amber L Beitelshees; Nihal El Rouby; Timo P Hiltunen; Jeffrey R O'Connell; Sandosh Padmanabhan; Taimour Y Langaee; Karen Hall; Siegfried O F Schmidt; Robert W Curry; John G Gums; Kati M Donner; Kimmo K Kontula; Kent R Bailey; Eric Boerwinkle; Atsushi Takahashi; Toshihiro Tanaka; Michiaki Kubo; Arlene B Chapman; Stephen T Turner; Carl J Pepine; Rhonda M Cooper-DeHoff; Julie A Johnson
Journal:  J Hypertens       Date:  2015-11       Impact factor: 4.844

6.  Verapamil versus hydrochlorothiazide in the treatment of hypertension: results of long term double blind comparative trial. Verapamil versus Diuretic (VERDI) Trial Research Group.

Authors:  H Holzgreve; A Distler; J Michaelis; T Philipp; S Wellek
Journal:  BMJ       Date:  1989-10-07

7.  The effectiveness of labetalol compared to hydrochlorothiazide in hypertensive black patients.

Authors:  C Lucas; P Jenkins; J Mendels; D Due; W P Forbes; M A Sirgo
Journal:  J Natl Med Assoc       Date:  1991-10       Impact factor: 1.798

8.  Baseline Serum Aldosterone-to-Renin Ratio is Associated with the Add-on Effect of Thiazide Diuretics in Non-Diabetic Essential Hypertensives.

Authors:  Chin-Chou Huang; Hsin-Bang Leu; Po-Hsun Huang; Tao-Cheng Wu; Shing-Jong Lin; Jaw-Wen Chen
Journal:  Acta Cardiol Sin       Date:  2013-01       Impact factor: 2.672

9.  Transdermal clonidine application: long-term results in essential hypertension.

Authors:  H Groth; H Vetter; J Knüsel; E Foerster; W Siegenthaler; W Vetter
Journal:  Klin Wochenschr       Date:  1984-10-01

Review 10.  The efficacy of beta-adrenoceptor and calcium-entry blockers in hypertensive blacks.

Authors:  J R M'Buyamba-Kabangu; M Tambwe
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.